34,367 Shares in Kadmon Holdings Inc (KDMN) Acquired by KCG Holdings Inc.
KCG Holdings Inc. acquired a new position in Kadmon Holdings Inc (NASDAQ:KDMN) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 34,367 shares of the company’s stock, valued at approximately $124,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Renaissance Technologies LLC bought a new position in shares of Kadmon Holdings during the first quarter worth approximately $158,000. Bank of New York Mellon Corp increased its position in shares of Kadmon Holdings by 302.3% in the first quarter. Bank of New York Mellon Corp now owns 46,304 shares of the company’s stock worth $167,000 after buying an additional 34,794 shares during the last quarter. Wells Fargo & Company MN increased its position in shares of Kadmon Holdings by 84.8% in the first quarter. Wells Fargo & Company MN now owns 51,291 shares of the company’s stock worth $186,000 after buying an additional 23,541 shares during the last quarter. Nationwide Fund Advisors bought a new position in shares of Kadmon Holdings during the first quarter worth approximately $192,000. Finally, AE Wealth Management LLC bought a new position in shares of Kadmon Holdings during the first quarter worth approximately $391,000.
Kadmon Holdings Inc (NASDAQ KDMN) traded down 1.7639% on Thursday, hitting $2.2889. The stock had a trading volume of 15,411 shares. The firm’s market cap is $118.67 million. The firm’s 50-day moving average price is $3.12 and its 200-day moving average price is $3.19. Kadmon Holdings Inc has a 1-year low of $2.05 and a 1-year high of $10.48.
Kadmon Holdings (NASDAQ:KDMN) last released its quarterly earnings results on Thursday, August 3rd. The company reported ($0.44) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.49) by $0.05. The business had revenue of $3 million for the quarter, compared to analyst estimates of $3.46 million. During the same period in the prior year, the business earned ($4.40) earnings per share. The company’s revenue for the quarter was down 53.1% on a year-over-year basis. On average, equities research analysts predict that Kadmon Holdings Inc will post ($1.58) earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: “34,367 Shares in Kadmon Holdings Inc (KDMN) Acquired by KCG Holdings Inc.” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at https://www.watchlistnews.com/34367-shares-in-kadmon-holdings-inc-kdmn-acquired-by-kcg-holdings-inc/1470622.html.
Several research analysts have recently issued reports on the company. Piper Jaffray Companies set a $7.00 price target on Kadmon Holdings and gave the stock a “buy” rating in a research note on Wednesday, August 2nd. Zacks Investment Research cut Kadmon Holdings from a “buy” rating to a “hold” rating in a research note on Tuesday, May 23rd. ValuEngine cut Kadmon Holdings from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. Finally, HC Wainwright reissued a “buy” rating and issued a $25.00 price target on shares of Kadmon Holdings in a research note on Monday, June 26th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $9.93.
In related news, major shareholder Goldentree Asset Management Lp sold 515,643 shares of the firm’s stock in a transaction on Monday, June 26th. The stock was sold at an average price of $3.51, for a total transaction of $1,809,906.93. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Over the last ninety days, insiders have purchased 9,707 shares of company stock valued at $22,944 and have sold 1,840,331 shares valued at $6,193,607.
Kadmon Holdings Company Profile
Kadmon Holdings, Inc is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs. The Company is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases.
Want to see what other hedge funds are holding KDMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kadmon Holdings Inc (NASDAQ:KDMN).
Receive News & Ratings for Kadmon Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kadmon Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.